PKMYT1 and cancer: The above results suggest that PKMYT1 reduces β-catenin degradation by blocking E3-ligase SCFβ-TrCP binding to β-catenin, leading to the constitutive activation of Wnt signaling and self-renewal of cancer stem cells.